Martin Mccabe

If you made any changes in Pure these will be visible here soon.

Filter

Advisory board member for Cabozantinib in bone sarcoma
Martin Mccabe (Academic founder)
27 Feb 2019
Activity: Consultancy, spin-outs, CPD & licensing › Consultancy & Services › Research
Review of patient information
Martin Mccabe (Advisor)
2015 → 2016
Activity: Consultancy, spin-outs, CPD & licensing › Consultancy & Services › Research
Review of TYA patient information
Martin Mccabe (Advisor)
2014
Activity: Consultancy, spin-outs, CPD & licensing › Consultancy & Services › Research

Activities